Lactation. Advise a lactating woman not to breastfeed during treatment with CABOMETYX and for 4 months after the final dose.
Appears in 2 contracts
Sources: Collaboration and License Agreement (Exelixis, Inc.), Clinical Trial Collaboration Agreement (Exelixis, Inc.)
Lactation. Advise a lactating woman women not to breastfeed during treatment with CABOMETYX and for 4 months 3 weeks after the final last dose.. •
Appears in 1 contract
Sources: License and Collaboration Agreement (Nuvation Bio Inc.)